These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10233785)

  • 21. PROMISE results slam milrinone.
    Br J Hosp Med; 1991 Apr; 45(4):233. PubMed ID: 1676326
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
    Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
    Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New positive inotropic agents in the treatment of left ventricular dysfunction.
    De Luca L; Proietti P; Palombaro GL; Battagliese A; Celotto A; Bucciarelli Ducci C; Fedele F
    Ital Heart J; 2004 Jun; 5 Suppl 6():63S-67S. PubMed ID: 15185917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should we use outpatient dobutamine or milrinone?
    Kato M; Sanada S; Kitakaze M
    Circ Heart Fail; 2009 Jul; 2(4):377-8. PubMed ID: 19808362
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of pitavastin in Japanese patients with chronic heart failure.
    D'Imperio H; Sanchis J; Núñez E; Núñez J
    Circ J; 2013; 77(8):2204. PubMed ID: 23759657
    [No Abstract]   [Full Text] [Related]  

  • 26. Diuretics in the treatment of heart failure: mainstay of therapy or potential hazard?
    Krum H; Cameron P
    J Card Fail; 2006 Jun; 12(5):333-5. PubMed ID: 16762793
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lower digitalis dosage in heart failure].
    Madsen S; Holene E
    Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1053-4. PubMed ID: 17457392
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of pitavastatin in Japanese patients with chronic heart failure. Reply.
    Takano H
    Circ J; 2013; 77(8):2205. PubMed ID: 23759658
    [No Abstract]   [Full Text] [Related]  

  • 29. Side effects of amrinone therapy.
    Wilsmhurst PT; Webb-Peploe MM
    Br Heart J; 1983 May; 49(5):447-51. PubMed ID: 6838732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Heart function and clinical observations of patients with severe congestive heart failure treated with milrinone].
    Lu G; Zheng Z; Zhang L
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Feb; 19(1):27-9. PubMed ID: 10322703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin therapy in chronic heart failure: frog prince or bare frog?
    Kihara Y
    Circ J; 2013; 77(4):895-7. PubMed ID: 23502989
    [No Abstract]   [Full Text] [Related]  

  • 32. Hydralazine and nitrates: beyond race and ethnicity.
    Ghali JK
    J Card Fail; 2007 Apr; 13(3):238. PubMed ID: 17448423
    [No Abstract]   [Full Text] [Related]  

  • 33. Update on digoxin therapy in congestive heart failure.
    Haji SA; Movahed A
    Am Fam Physician; 2000 Jul; 62(2):409-16. PubMed ID: 10929703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tailored treatment for heart failure.
    Shibata M; Perez de Arenaza D
    Lancet; 2000 Aug; 356(9230):686. PubMed ID: 10968472
    [No Abstract]   [Full Text] [Related]  

  • 35. Digoxin for the treatment of heart failure.
    Hallberg P; Michaëlsson K; Melhus H
    N Engl J Med; 2003 Feb; 348(7):661-3; author reply 661-3. PubMed ID: 12587575
    [No Abstract]   [Full Text] [Related]  

  • 36. Amrinone-induced hepatotoxicity.
    Gilman ME; Margolis SC
    Clin Pharm; 1984; 3(4):422-4. PubMed ID: 6467879
    [No Abstract]   [Full Text] [Related]  

  • 37. [Risk factors for dying among ibopamine users].
    Vandenbroucke JP
    Ned Tijdschr Geneeskd; 1999 Jul; 143(31):1631-2. PubMed ID: 10488378
    [No Abstract]   [Full Text] [Related]  

  • 38. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
    Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
    Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Phosphodiesterase inhibitors--a new therapeutic principle in heart failure].
    Erhardt L
    Lakartidningen; 1988 Nov; 85(44):3662-3. PubMed ID: 3199999
    [No Abstract]   [Full Text] [Related]  

  • 40. [Is heart rate reduction beneficial to patients with heart insufficiency? Focus on beta-blockade].
    Henriksen OM; Gadsbøll N
    Ugeskr Laeger; 2002 Jan; 164(5):615-9. PubMed ID: 11871210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.